Eversept Partners, LP
- SEC CIK
- 0001697013
Holdings, Q2 2026
Positions as of Jun 30, 2026, filed Aug 14, 2026.SEC
- Positions
- 115
- +11 vs. Q1 2026
- Total value
- $1.83B
- +$316.92M (+20.9%) vs. Q1 2026
Compare with Q1 2026: new, added, reduced and sold out
Positions
Long positions only. Changes compare share counts with Q1 2026.
| Security | Class | Shares | Value | % of portfolio | Change in shares | Action | History |
|---|---|---|---|---|---|---|---|
| UTHRUNITED THERAPEUTICS CORP DEL | COM | 287,668 | $155.87M | 8.50% | +23,397+8.9% | Added | View |
| ABVXABIVAX SA | SPONSORED ADS | 913,880 | $121.78M | 6.64% | −20,543−2.2% | Reduced | View |
| EHCENCOMPASS HEALTH CORP | COM | 1,026,919 | $103.8M | 5.66% | +832,815+429.1% | Added | View |
| ENSGENSIGN GROUP INC | COM | 602,079 | $96.51M | 5.26% | +587,318+3,978.8% | Added | View |
| VERAVERA THERAPEUTICS INC | CL A | 2,212,770 | $94.95M | 5.18% | +39,484+1.8% | Added | View |
| CLDXCELLDEX THERAPEUTICS INC NEW | COM NEW | 1,785,941 | $66.45M | 3.62% | −2,075−0.1% | Reduced | View |
| SNDXSYNDAX PHARMACEUTICALS INC | COM | 2,798,210 | $61.17M | 3.33% | −87,412−3.0% | Reduced | View |
| BKDBROOKDALE SR LIVING INC | COM | 3,396,470 | $54.65M | 2.98% | −172,085−4.8% | Reduced | View |
| IONSIONIS PHARMACEUTICALS INC | COM | 664,684 | $52.7M | 2.87% | +32,584+5.2% | Added | View |
| NTRANATERA INC | COM | 175,807 | $47.72M | 2.60% | −208,906−54.3% | Reduced | View |
| TVTXTRAVERE THERAPEUTICS INC | COM | 798,973 | $45.39M | 2.47% | +256,363+47.2% | Added | View |
| CTRECARETRUST REIT INC | COM | 1,072,015 | $43.26M | 2.36% | +1,072,015 | New | View |
| HCAHCA HEALTHCARE INC | COM | 98,252 | $38.31M | 2.09% | +19,023+24.0% | Added | View |
| PCVXVAXCYTE INC | COM | 629,952 | $36.62M | 2.00% | −294,241−31.8% | Reduced | View |
| LQDALIQUIDIA CORPORATION | COM NEW | 428,652 | $34.18M | 1.86% | −248,740−36.7% | Reduced | View |
| CYHCOMMUNITY HEALTH SYS INC NEW | COM | 7,864,575 | $26.27M | 1.43% | −812,706−9.4% | Reduced | View |
| GSKGSK PLC SPONSORED ADR | ADR | 481,833 | $25.26M | 1.38% | −1,303,342−73.0% | Reduced | View |
| CHECHEMED CORP NEW | COM | 52,523 | $24.46M | 1.33% | +21,466+69.1% | Added | View |
| LLYELI LILLY & CO COM | Stock | 20,116 | $24.13M | 1.32% | +1,116+5.9% | Added | View |
| GERNGERON CORP | COM | 18,717,422 | $23.96M | 1.31% | −117,461−0.6% | Reduced | View |
| VKTXVIKING THERAPEUTICS INC | COM | 602,922 | $23.52M | 1.28% | +363,812+152.2% | Added | View |
| OHIOMEGA HEALTHCARE INVS INC | COM | 483,547 | $23.06M | 1.26% | −102,133−17.4% | Reduced | View |
| PODDINSULET CORP COM | Stock | 148,816 | $22.66M | 1.24% | +5,270+3.7% | Added | View |
| THCTENET HEALTHCARE CORP | COM NEW | 114,199 | $21.36M | 1.16% | +84,687+287.0% | Added | View |
| UNHUNITEDHEALTH GROUP INC COM | Stock | 51,145 | $21.26M | 1.16% | +51,145 | New | View |
| WELLWELLTOWER INC COM | REIT | 87,312 | $19.82M | 1.08% | −93,641−51.7% | Reduced | View |
| BBNXBETA BIONICS INC | COM | 1,249,441 | $19.58M | 1.07% | −165,397−11.7% | Reduced | View |
| COGTCOGENT BIOSCIENCES INC | COM | 490,235 | $18.97M | 1.03% | +490,235 | New | View |
| BCRXBIOCRYST PHARMACEUTICALS INC | COM | 1,865,653 | $18.66M | 1.02% | −1,174,167−38.6% | Reduced | View |
| MOHMOLINA HEALTHCARE INC | COM | 80,594 | $18.43M | 1.00% | +47,783+145.6% | Added | View |
| PNTGPENNANT GROUP INC | COM | 460,272 | $17.01M | 0.93% | +148,094+47.4% | Added | View |
| LTCLTC PPTYS INC COM | REIT | 420,640 | $16.17M | 0.88% | +99,594+31.0% | Added | View |
| INSMINSMED INC | COM PAR $.01 | 149,209 | $15.91M | 0.87% | +149,209 | New | View |
| VRDNVIRIDIAN THERAPEUTICS INC | COM | 831,142 | $15.27M | 0.83% | +117,873+16.5% | Added | View |
| BMRNBIOMARIN PHARMACEUTICAL INC | COM | 249,607 | $14.28M | 0.78% | +41,839+20.1% | Added | View |
| AMNAMN HEALTHCARE SVCS INC | COM | 428,531 | $13.87M | 0.76% | +428,531 | New | View |
| CELCCELCUITY INC | COM | 127,931 | $13.38M | 0.73% | +127,931 | New | View |
| PHVSPHARVARIS N V | COM | 386,383 | $13.36M | 0.73% | −20,577−5.1% | Reduced | View |
| CTMXCYTOMX THERAPEUTICS INC. | COM | 3,558,497 | $13.34M | 0.73% | +369,983+11.6% | Added | View |
| HUMHUMANA INC COM | Stock | 31,171 | $12.38M | 0.67% | +31,171 | New | View |
| XENEXENON PHARMACEUTICALS INC | COM | 196,532 | $11.86M | 0.65% | +66,958+51.7% | Added | View |
| CRVSCORVUS PHARMACEUTICALS INC | COM | 747,994 | $11.18M | 0.61% | +747,994 | New | View |
| ASNDASCENDIS PHARMA A/S | ORD SHS | 41,621 | $11.1M | 0.61% | +41,621 | New | View |
| BRKRBRUKER CORP | COM | 182,894 | $11.01M | 0.60% | +65,881+56.3% | Added | View |
| MRNAMODERNA INC COM | Stock | 152,122 | $10.65M | 0.58% | −7,586−4.7% | Reduced | View |
| GPCRSTRUCTURE THERAPEUTICS INC | SPONSORED ADS | 196,302 | $10.54M | 0.57% | +58,266+42.2% | Added | View |
| DFTXDEFINIUM THERAPEUTICS INC | COM SHS | 217,185 | $10.22M | 0.56% | +56,462+35.1% | Added | View |
| CMPSCOMPASS PATHWAYS PLC | SPONSORED ADS | 672,825 | $9.52M | 0.52% | −5,099−0.8% | Reduced | View |
| NAMSNEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | 275,471 | $9.34M | 0.51% | −10,293−3.6% | Reduced | View |
| RVTYREVVITY INC | COM | 83,624 | $9.3M | 0.51% | −1,230−1.4% | Reduced | View |
| PALIPALISADE BIO INC | COM | 4,182,785 | $8.74M | 0.48% | −804,714−16.1% | Reduced | View |
| ARDXARDELYX INC | COM | 1,678,345 | $8.56M | 0.47% | −551,101−24.7% | Reduced | View |
| MLYSMINERALYS THERAPEUTICS INC | COM | 309,689 | $8.36M | 0.46% | +309,689 | New | View |
| RLAYRELAY THERAPEUTICS INC | COM | 434,314 | $8.13M | 0.44% | +163,609+60.4% | Added | View |
| NVONOVO-NORDISK A S ADR | ADR | 169,227 | $8.11M | 0.44% | +169,227 | New | View |
| BHVNBIOHAVEN LTD | COM | 515,804 | $7.68M | 0.42% | +515,804 | New | View |
| PTGXPROTAGONIST THERAPEUTICS INC | COM | 58,504 | $7.17M | 0.39% | +58,504 | New | View |
| ELVNENLIVEN THERAPEUTICS INC | COM | 136,631 | $6.93M | 0.38% | +136,631 | New | View |
| REPLREPLIMUNE GROUP INC | COM | 590,252 | $6.53M | 0.36% | +255,391+76.3% | Added | View |
| LBRXLB PHARMACEUTICALS INC | COM SHS | 183,663 | $5.96M | 0.32% | +83,465+83.3% | Added | View |
| BEAMBEAM THERAPEUTICS INC | COM | 166,289 | $5.71M | 0.31% | +166,289 | New | View |
| NHINATIONAL HEALTH INVS INC | COM | 70,673 | $5.39M | 0.29% | +70,673 | New | View |
| RAREULTRAGENYX PHARMACEUTICAL IN | COM | 154,130 | $5.15M | 0.28% | +91,555+146.3% | Added | View |
| PACSPACS GROUP INC | COM SHS | 117,441 | $5.01M | 0.27% | +117,441 | New | View |
| EQEQUILLIUM INC | COM | 1,520,824 | $4.87M | 0.27% | +21,831+1.5% | Added | View |
| ANABANAPTYSBIO INC | COM | 69,983 | $4.72M | 0.26% | +42,894+158.3% | Added | View |
| NHCNATIONAL HEALTHCARE CORP | COM | 22,116 | $4.67M | 0.25% | +22,116 | New | View |
| EYPTEYEPOINT INC | COM NEW | 297,735 | $4.26M | 0.23% | +297,735 | New | View |
| SNDASONIDA SENIOR LIVING INC | COM | 102,624 | $4.19M | 0.23% | +74,187+260.9% | Added | View |
| GKOSGLAUKOS CORP | COM | 29,343 | $4.1M | 0.22% | −30,871−51.3% | Reduced | View |
| AGLAGILON HEALTH INC | COM NEW | 37,792 | $4.05M | 0.22% | −138,796−78.6% | Reduced | View |
| ARQTARCUTIS BIOTHERAPEUTICS INC | COM | 135,355 | $3.55M | 0.19% | −441,225−76.5% | Reduced | View |
| TARSTARSUS PHARMACEUTICALS INC | COM | 55,710 | $3.51M | 0.19% | +55,710 | New | View |
| ANROALTO NEUROSCIENCE INC | COM SHS | 128,286 | $3.39M | 0.18% | +3,118+2.5% | Added | View |
| SPRYARS PHARMACEUTICALS INC | COM | 377,007 | $3.02M | 0.16% | +240,772+176.7% | Added | View |
| IFRXINFLARX NV | COM | 1,304,069 | $2.92M | 0.16% | −454,504−25.8% | Reduced | View |
| ISRGINTUITIVE SURGICAL INC | COM NEW | 7,241 | $2.88M | 0.16% | −3,878−34.9% | Reduced | View |
| ALECALECTOR INC | COM | 1,423,873 | $2.86M | 0.16% | +72,767+5.4% | Added | View |
| VORVOR BIOPHARMA INC | COM NEW | 149,681 | $2.76M | 0.15% | +149,681 | New | View |
| DSGNDESIGN THERAPEUTICS INC | COM | 190,000 | $2.75M | 0.15% | +190,000 | New | View |
| KPTIKARYOPHARM THERAPEUTICS INC | COM NEW | 276,174 | $2.7M | 0.15% | 00.0% | Unchanged | View |
| PMVPPMV PHARMACEUTICALS INC | COM | 1,890,904 | $2.53M | 0.14% | −457,456−19.5% | Reduced | View |
| CTNMCONTINEUM THERAPEUTICS INC | CL A | 148,017 | $2.43M | 0.13% | +1,606+1.1% | Added | View |
| EVMNEVOMMUNE INC | COM SHS | 174,460 | $2.32M | 0.13% | +119,780+219.1% | Added | View |
| AMRNAMARIN CORP PLC | SPONSORED ADR | 145,296 | $2.32M | 0.13% | −2,419−1.6% | Reduced | View |
| SPRBSPRUCE BIOSCIENCES INC | COM NEW | 40,000 | $2.16M | 0.12% | +40,000 | New | View |
| RGENREPLIGEN CORP | COM | 14,401 | $1.96M | 0.11% | −106,384−88.1% | Reduced | View |
| IVVDINVIVYD INC | COM | 2,237,015 | $1.95M | 0.11% | −39,334−1.7% | Reduced | View |
| PRQRPROQR THRAPEUTICS N V | SHS EURO | 1,022,265 | $1.9M | 0.10% | +1,022,265 | New | View |
| GRCEACASTI PHARMA INC | CL A | 772,900 | $1.75M | 0.10% | +16,300+2.2% | Added | View |
| AVRANTERIS TECHNOLOGIES GLOBAL | COM | 166,229 | $1.64M | 0.09% | −234,958−58.6% | Reduced | View |
| VIRVIR BIOTECHNOLOGY INC | COM | 156,636 | $1.6M | 0.09% | −93,364−37.3% | Reduced | View |
| EDITEDITAS MEDICINE INC | COM | 458,809 | $1.49M | 0.08% | +167,890+57.7% | Added | View |
| WHWKWHITEHAWK THERAPEUTICS INC | COM | 303,306 | $1.39M | 0.08% | −3,494−1.1% | Reduced | View |
| TECHBIO-TECHNE CORP | COM | 19,308 | $1.36M | 0.07% | −106,588−84.7% | Reduced | View |
| RVMDREVOLUTION MEDICINES INC | COM | 6,943 | $1.3M | 0.07% | +6,943 | New | View |
| SVRASAVARA INC | COM | 204,428 | $1.26M | 0.07% | −179,836−46.8% | Reduced | View |
| SRZNSURROZEN INC | COM NEW | 47,777 | $1.24M | 0.07% | −10,847−18.5% | Reduced | View |
| INOINOVIO PHARMACEUTICALS INC | COM SHS | 1,035,360 | $1.14M | 0.06% | 00.0% | Unchanged | View |
| PLRXPLIANT THERAPEUTICS INC | COM | 891,425 | $1.02M | 0.06% | 00.0% | Unchanged | View |
Options (5)
Put and call positions reported in the same filing. The value is that of the underlying shares, as reported on Form 13F.
Sold out since Q1 2026 (21)
Positions held at the end of Q1 2026 that are no longer in this filing.
| Security | Class | Shares, Q1 2026 | Value, Q1 2026 | % of portfolio, Q1 2026 |
|---|---|---|---|---|
| DOCHEALTHPEAK PROPERTIES INC | COM | 1,981,070 | $32.55M | 2.14% |
| AVTRAVANTOR INC | COM | 2,974,287 | $23.32M | 1.54% |
| QGENQIAGEN NV | ORD SHARES | 545,330 | $21.84M | 1.44% |
| ICLRICON PLC | COM | 68,688 | $7.6M | 0.50% |
| AGIOAGIOS PHARMACEUTICALS INC | COM | 200,000 | $6.77M | 0.45% |
| MDGLMADRIGAL PHARMACEUTICALS INC | COM | 10,000 | $5.23M | 0.34% |
| ESPERION THERAPEUTICS INC NE29664W105 | COM | 1,735,963 | $4.76M | 0.31% |
| HQYHEALTHEQUITY INC | COM | 51,614 | $4.31M | 0.28% |
| DAY ONE BIOPHARMACEUTICALS INC COM23954D109 | Stock | 183,902 | $3.94M | 0.26% |
| CNCCENTENE CORP DEL COM | Stock | 111,652 | $3.66M | 0.24% |
| ENGNENGENE HOLDINGS INC | COM | 510,543 | $3.48M | 0.23% |
| ENHABIT INC29332G102 | COM | 227,451 | $3.2M | 0.21% |
| STROSUTRO BIOPHARMA INC | COM SHS | 73,161 | $1.82M | 0.12% |
| NVCRNOVOCURE LTD | ORD SHS | 134,917 | $1.47M | 0.10% |
| BVSBIOVENTUS INC | COM CL A | 159,110 | $1.45M | 0.10% |
| IMCRIMMUNOCORE HLDGS PLC | ADS | 39,238 | $1.18M | 0.08% |
| TYRATYRA BIOSCIENCES INC | COM | 27,055 | $1.04M | 0.07% |
| PASGPassage Bio Inc | COM | 131,581 | $1.03M | 0.07% |
| DHCDIVERSIFIED HEALTHCARE TR | COM SH BEN INT | 151,283 | $1M | 0.07% |
| INMDINMODE LTD | SHS | 67,744 | $926.74K | 0.06% |
| AIRSAIRSCULPT TECHNOLOGIES INC | COM | 74,139 | $209.81K | 0.01% |
13F filings by quarter
| Quarter | Filed | Positions | Total value | Changes | Filing |
|---|---|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | 115 | $1.83B | vs. Q1 2026 | SEC |
| Q1 2026 | May 15, 2026 | 104 | $1.52B | vs. Q4 2025 | SEC |
| Q4 2025 | Feb 17, 2026 | 103 | $1.78B | vs. Q3 2025 | SEC |
| Q3 2025 | Nov 14, 2025 | 83 | $1.31B | vs. Q2 2025 | SEC |
| Q2 2025 | Aug 14, 2025 | 67 | $992.23M | vs. Q1 2025 | SEC |
| Q1 2025 | May 15, 2025 | 55 | $883.69M | vs. Q4 2024 | SEC |
| Q4 2024 | Feb 14, 2025 | 62 | $969.07M | vs. Q3 2024 | SEC |
| Q3 2024 | Nov 14, 2024 | 65 | $1.3B | vs. Q2 2024 | SEC |
| Q2 2024 | Aug 14, 2024 | 72 | $1.31B | vs. Q1 2024 | SEC |
| Q1 2024 | May 15, 2024 | 68 | $1.34B | vs. Q4 2023 | SEC |
| Q4 2023 | Feb 14, 2024 | 55 | $1.02B | vs. Q3 2023 | SEC |
| Q3 2023 | Nov 14, 2023 | 61 | $900.72M | vs. Q2 2023 | SEC |
| Q2 2023 | Nov 8, 2023Amended | 66 | $946.89M | vs. Q1 2023 | SEC |
| Q1 2023 | Nov 8, 2023Amended | 58 | $1.11B | vs. Q4 2022 | SEC |
| Q4 2022 | Nov 8, 2023Amended | 62 | $1.05B | vs. Q3 2022 | SECSEC |
| Q3 2022 | Nov 8, 2023Amended | 60 | $843.15M | vs. Q2 2022 | SECSEC |
| Q2 2022 | Nov 8, 2023Amended | 65 | $1.02B | vs. Q1 2022 | SECSEC |
| Q1 2022 | Nov 8, 2023Amended | 76 | $1.09B | vs. Q4 2021 | SEC |
| Q4 2021 | Nov 8, 2023Amended | 90 | $1.21B | vs. Q3 2021 | SECSEC |
| Q3 2021 | Nov 8, 2023Amended | 88 | $1.25B | vs. Q2 2021 | SECSEC |
| Q2 2021 | Nov 8, 2023Amended | 69 | $1.08B | vs. Q1 2021 | SEC |
| Q1 2021 | Nov 8, 2023Amended | 74 | $1.22B | – | SECSEC |